FFCP PHASE1:Mm9::chr10:117535326..117535337,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=6|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr10:117535326..117535337,+|id=chr10:117535326..117535337,+|ontology_enrichment_celltype=CL:0000049!2.59e-09!19;CL:0000553!3.28e-08!6;CL:0000556!3.28e-08!6|ontology_enrichment_celltype_v019_2=CL:0000355,3.69e-15,9|ontology_enrichment_disease=DOID:0060100!4.51e-17!3;DOID:4045!4.51e-17!3;DOID:0050686!8.47e-09!6|ontology_enrichment_disease_v019_2=DOID:0060100,1.25e-43,3;DOID:4045,1.25e-43,3;DOID:0050686,2.64e-22,6|ontology_enrichment_uberon=UBERON:0002204!1.95e-07!32|ontology_enrichment_uberon_v019_2=UBERON:0001134,3.69e-15,9;UBERON:0002036,3.69e-15,9;UBERON:0002385,3.69e-15,9;UBERON:0000486,3.69e-15,9;UBERON:0007503,3.69e-15,9;UBERON:0001015,3.69e-15,9;UBERON:0002329,3.69e-15,9;UBERON:0003082,3.69e-15,9;UBERON:0003059,3.69e-15,9;UBERON:0007282,3.69e-15,9;UBERON:0004290,3.69e-15,9;UBERON:0009618,3.69e-15,9;UBERON:0000383,1.00e-13,10;UBERON:0007524,1.50e-12,11;UBERON:0003077,1.50e-12,11;UBERON:0007285,1.50e-12,11|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.202475267389826,0,0.473193248037357,0.137114433605739,0,0,0,0,0.159992422793407,0,0,0,0,0,0,0,0,0,0,0,0,0,17.5783284909501,23.440060335714,10.470474879476,75.8818619560008,34.1522742479223,13.1087795318411,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.484875253135222,0,0,0,0,0.11981512450592,0.599902730993408,0.254140454146129,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.184753190166605,0,0,0,0,0,0,0,0,0,0,0,0.172684981865896,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.177340233642274,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr10:117535326..117535337,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=6 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr10:117535326..117535337,+ | |||
|description=CAGE_peak_at_chr10:117535326..117535337,+ | |||
|id=chr10:117535326..117535337,+ | |||
|ontology_enrichment_celltype=CL:0000049!2.59e-09!19;CL:0000553!3.28e-08!6;CL:0000556!3.28e-08!6 | |||
|ontology_enrichment_celltype_v019_2=CL:0000355,3.69e-15,9 | |||
|ontology_enrichment_disease=DOID:0060100!4.51e-17!3;DOID:4045!4.51e-17!3;DOID:0050686!8.47e-09!6 | |||
|ontology_enrichment_disease_v019_2=DOID:0060100,1.25e-43,3;DOID:4045,1.25e-43,3;DOID:0050686,2.64e-22,6 | |||
|ontology_enrichment_uberon=UBERON:0002204!1.95e-07!32 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,3.69e-15,9;UBERON:0002036,3.69e-15,9;UBERON:0002385,3.69e-15,9;UBERON:0000486,3.69e-15,9;UBERON:0007503,3.69e-15,9;UBERON:0001015,3.69e-15,9;UBERON:0002329,3.69e-15,9;UBERON:0003082,3.69e-15,9;UBERON:0003059,3.69e-15,9;UBERON:0007282,3.69e-15,9;UBERON:0004290,3.69e-15,9;UBERON:0009618,3.69e-15,9;UBERON:0000383,1.00e-13,10;UBERON:0007524,1.50e-12,11;UBERON:0003077,1.50e-12,11;UBERON:0007285,1.50e-12,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.202475267389826,0,0.473193248037357,0.137114433605739,0,0,0,0,0.159992422793407,0,0,0,0,0,0,0,0,0,0,0,0,0,17.5783284909501,23.440060335714,10.470474879476,75.8818619560008,34.1522742479223,13.1087795318411,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.484875253135222,0,0,0,0,0.11981512450592,0.599902730993408,0.254140454146129,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.184753190166605,0,0,0,0,0,0,0,0,0,0,0,0.172684981865896,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.177340233642274,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr10:117535326..117535337,+ | |||
}} |
Latest revision as of 22:46, 3 August 2015
Short description: | p@chr10:117535326..117535337, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr10:117535326..117535337, + |
Coexpression cluster: | MCL_coexpression_mm9:6 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
multi-potent skeletal muscle stem cell | 3.69e-15 | 9 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 3.69e-15 | 9 |
striated muscle tissue | 3.69e-15 | 9 |
muscle tissue | 3.69e-15 | 9 |
multilaminar epithelium | 3.69e-15 | 9 |
epithelial vesicle | 3.69e-15 | 9 |
musculature | 3.69e-15 | 9 |
somite | 3.69e-15 | 9 |
myotome | 3.69e-15 | 9 |
presomitic mesoderm | 3.69e-15 | 9 |
presumptive segmental plate | 3.69e-15 | 9 |
dermomyotome | 3.69e-15 | 9 |
trunk paraxial mesoderm | 3.69e-15 | 9 |
musculature of body | 1.00e-13 | 10 |
dense mesenchyme tissue | 1.50e-12 | 11 |
paraxial mesoderm | 1.50e-12 | 11 |
presumptive paraxial mesoderm | 1.50e-12 | 11 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 1.25e-43 | 3 |
muscle cancer | 1.25e-43 | 3 |
organ system cancer | 2.64e-22 | 6 |